Avaliação do efeito protetor do extrato de Gingko biloba na osteoporose induzida por glicocorticóide em ratas Wistar
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Introduction: Osteoporosis is a disease characterized by the reduction of bone
volume. Among the main causes of osteoporosis is the reduction of the levels of
estrogen and the chronic use of glucocorticoids. Several products are used on the
osteoporosis treatment, including natural products, among them some promising
alternatives as the phytoestrogens. In vitro studies showed that the extract of Ginkgo
biloba (EGb) has a estrogenic effect and a protect action on the osteoblasts cell.
Therefore the EGb may be important in the treatment of osteoporosis. Methods: 72
female rats were divided into six groups: control, osteoporosis, positive control
(sodium alendronate-0.2mg/Kg/day), EGb1 (14mg/Kg/day), EGb2 (28mg/Kg/day) and
(56mg/Kg/day). Osteoporosis induction was done trough intramuscular injection of
dexamethasone in a dose of 7mg/Kg, once a week, during five weeks. Treatments
were conducted after osteoporosis induction for 20 and 30 days. Following
euthanazia, the left mandibles were removed for the digital radiographic analysis.
The cortical and the periodontal bone support (PBS) at the mesial and distal surfaces
of the first molar were analyzed. For the histomorphometric analysis the right femurs
and mandibles were removed to evaluate the percentage of the trabecular bone
(PTB) of the femur epiphysis and the percentage of the alveolar bone (PAB) of the
interradicular septum of the second molar.
The control groups were compared with the osteoporosis group (Student’s t-test).
The others groups, except the control groups, were analyzed by ANOVA test
followed by Tukey or Dunnett’s post-hoc test (p<0.05). Results: It was observed
trough the mandibular radiographic analysis that the glucocorticoid caused the PBS
reduction, the sodium alendronate recovered the percentage of PBS in the same way
that EGb in the 28mg/kg/day and 56mg/kg/day doses in the treatments of 20 and 30
days. The EGb3 showed increase in the cortical mandibular thickness in the
treatments of 20 and 30 days. Trough the histomorphometric analysis of the animals
treated for 30 and 20 days, it was observed that glucocorticoids reduced the PTB of
the femur and the PAB of the mandible (p<0,05). The positive control group (30 days)
showed a statistical significant increase of the PTB of the femur when compared to
the osteoporosis group (30 days). The PAB of the mandible in the positive control
group showed no significant increase when compared to the osteoporosis group (20
and 30 days). The groups EGb1 and EGb2 groups showed an increase of the PTB of
the femur when compared to the osteoporosis group (20 and 30 days), in the same
way the EGb2 and EGb3 groups (20 days) and the EGb1, EGb2, and EGB3 groups
(30 days) showed a statically significant increase of the PAB when compared to the
osteoporosis group. Conclusion: The EGb recovered the effects oft glucocorticoid
induced-osteoporosis in the evaluated parameters of this study, it suggests that the
extract of Ginkgo biloba may be effective in the treatment of osteoporosis.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
